Jha MK
Center for Depression Research and Clinical Care, Peter O'Donnell Jr. Brain Institute and Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States of America.
ArticleKetamine
Randomized controlled trial of acute ketamine versus midazolam for recurrence of suicidality in adolescents (TASK): Rationale, design, and baseline characteristics.
ArticlePsilocybin
Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications.
ArticleKetamine
Real-world evaluation of change in depressive symptoms among patients with treatment-resistant depression treated with esketamine.
ArticleKetamine
Combining Ketamine Infusions and Written Exposure Therapy for Chronic PTSD: An Open-Label Trial.
ArticlePsilocybin
Pharmacokinetics of Psilocybin: A Systematic Review.
ArticlePsilocybin
Psychedelics and Suicide-Related Outcomes: A Systematic Review.
ArticleKetamine
Mental Health-Related Disability Days and Costs Among Patients with Treatment-Resistant Depression Initiated on Esketamine Nasal Spray and Conventional Therapies in the USA.
ArticlePsilocybin
Role of Psychedelics in Treatment-Resistant Depression.
ArticlePsilocybin